ARCHIVES

Von Eschenbach says oncology is undergoing a “revolutionary evolution.”

This article is from The Cancer Letter archive.

Vol. 31 No. 20 | May 20, 2005

Download PDF Visit The Full Archive

Related Articles

Oncology Faces Cuts In CMS Revamp Of Physician Payments Under Part B.

July 10, 2009

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

April 24, 1998

DCT To Announce Three New CRAGs

November 12, 1976

Pacific Yew Act Would Result In Duplications, Delays In Taxol Production, Witnesses Say

March 13, 1992

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

Wong To Head MSKCC Colorectal Service; How You Know When To Stop Advising NCI.

June 29, 2001